Show simple item record

dc.contributor.authorNaidoo, K
dc.contributor.authorBeardsley, B
dc.contributor.authorCarder, PJ
dc.contributor.authorDeb, R
dc.contributor.authorFish, D
dc.contributor.authorGirling, A
dc.contributor.authorHales, S
dc.contributor.authorHowe, M
dc.contributor.authorWastall, LM
dc.contributor.authorLane, S
dc.contributor.authorLee, AHS
dc.contributor.authorPhilippidou, M
dc.contributor.authorQuinn, C
dc.contributor.authorStephenson, T
dc.contributor.authorPinder, SE
dc.date.accessioned2016-11-24T15:21:02Z
dc.date.issued2016-12-01
dc.identifier.citationJournal of clinical pathology, 2016, 69 (12), pp. 1122 - 1123
dc.identifier.issn0021-9746
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/306
dc.identifier.eissn1472-4146
dc.identifier.doi10.1136/jclinpath-2016-203886
dc.description.abstractAlthough the UK National Institute for Health and Care Excellence guidelines recommend that in patients with biopsy-proven invasive lobular carcinoma (ILC), preoperative MRI scan is considered, the accuracy of diagnosis of ILC in core biopsy of the breast has not been previously investigated. Eleven pathology laboratories from the UK and Ireland submitted data on 1112 cases interpreted as showing features of ILC, or mixed ILC and IDC/no special type (NST)/other tumour type, on needle core biopsy through retrieval of histology reports. Of the total 1112 cases, 844 were shown to be pure ILC on surgical excision, 154 were mixed ILC plus another type (invariably ductal/NST) and 113 were shown to be ductal/NST. Of those lesions categorised as pure ILC on core, 93% had an element of ILC correctly identified in the core biopsy sample and could be considered concordant. Of cores diagnosed as mixed ILC plus another type on core, complete agreement between core and excision was 46%, with 27% cases of pure ILC, whilst 26% non-concordant. These data indicate that there is not a large excess of expensive MRIs being performed as a result of miscategorisation histologically.
dc.formatPrint-Electronic
dc.format.extent1122 - 1123
dc.languageeng
dc.language.isoeng
dc.publisherBMJ
dc.subjectBreast
dc.subjectHumans
dc.subjectCarcinoma, Lobular
dc.subjectBreast Neoplasms
dc.subjectNeoplasm Invasiveness
dc.subjectDiagnostic Errors
dc.subjectMagnetic Resonance Imaging
dc.subjectReproducibility of Results
dc.subjectIreland
dc.subjectFemale
dc.subjectBiopsy, Large-Core Needle
dc.subjectUnited Kingdom
dc.titleAccuracy of classification of invasive lobular carcinoma on needle core biopsy of the breast.
dc.typeJournal Article
dcterms.dateAccepted2016-07-16
rioxxterms.versionofrecord10.1136/jclinpath-2016-203886
rioxxterms.licenseref.startdate2016-12
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfJournal of clinical pathology
pubs.issue12
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Target Validation and DNA Damage Response
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Target Validation and DNA Damage Response
pubs.publication-statusPublished
pubs.volume69
pubs.embargo.termsNo embargo
icr.researchteamTarget Validation and DNA Damage Response
dc.contributor.icrauthorNaidoo, Kalnisha


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record